NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $72,000 | -91.0% | 130,332 | -69.9% | 0.03% | -93.6% |
Q4 2018 | $796,000 | +17.9% | 432,344 | +20.4% | 0.44% | +128.6% |
Q3 2018 | $675,000 | +89.1% | 359,194 | +35.1% | 0.19% | +104.3% |
Q2 2018 | $357,000 | +1522.7% | 265,894 | +2432.3% | 0.09% | +1466.7% |
Q1 2018 | $22,000 | +69.2% | 10,500 | 0.0% | 0.01% | +100.0% |
Q4 2017 | $13,000 | +8.3% | 10,500 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $12,000 | -50.0% | 10,500 | -50.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | +84.6% | 21,000 | +100.0% | 0.00% | -57.1% |
Q1 2017 | $13,000 | -40.9% | 10,500 | 0.0% | 0.01% | -50.0% |
Q3 2016 | $22,000 | -71.1% | 10,500 | 0.0% | 0.01% | -68.2% |
Q2 2016 | $76,000 | +40.7% | 10,500 | 0.0% | 0.04% | +10.0% |
Q1 2016 | $54,000 | -38.6% | 10,500 | 0.0% | 0.04% | -36.5% |
Q4 2015 | $88,000 | – | 10,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |